Treatment Of Prostatic Hyperplasia Research Articles

Aspects of imaging in the assessment and follow up of benign prostatic hyperplasia.

For assessing patients suffering from benign prostatic hyperplasia and monitoring subsequent treatment, symptom questionnaires, uroflowmetry, prostate volume measurements, postvoiding residual urine volume measurements and pressure-flow studies may be used. This review highlights aspects of imaging in the assessment of benign prostatic hyperplasia, including volume determinations of prostate and postvoiding residual urine, texture imaging and biopsy guidance. Future developments are also briefly discussed.

Transurethral Hyperthermia in The Treatment of Prostatic Hyperplasia

Transurethral Hyperthermia in The Treatment of Prostatic Hyperplasia

前立腺癌および前立腺肥大症に対するハイパーサーミアの治療効果

前立腺癌および前立腺肥大症に対するハイパーサーミアの治療効果

5-fluorouracil (5-Fu) in the treatment of prostatic hyperplasia

A prospective study of 5-Fu in the treatment of prostatic hyperplasia was commenced in 1981. The short term results were fair in 70% of 43 patients. Atrophy of the glandular tissue could be observed on histopathologic examination. The study showed that the larger the glandular component the better was the therapeutic effect. If abundant fibromuscular tissue was present in the gland the treatment was unsatisfactory. Abnormal anatomy of the bladder neck, represented a contraindication to medical treatment.

A Comparative Study of Terazosin and Tamsulosin in Medical Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Key words: Tamsulosin; Terazosin; IPSS; Qmax; PVR DOI: 10.3329/jcmcta.v20i1.4933 Journal of Chittagong Medical College Teachers' Association 2009: 20(1):34-40